Salient Pharmaceuticals' Angel - II Round

Salient Pharmaceuticals raised a round of funding on August 24, 2009.

Salient Pharmaceuticals is a life science company developing a proprietary compound intended for use in treating severe diarrhea associated with chemotherapy, chronic conditions, infectious diseases a…

Articles about Salient Pharmaceuticals' Angel - II Round: